Arylcyclohexylamine
Arylcyclohexylamines, also known as arylcyclohexamines or arylcyclohexanamines, are a chemical class of pharmaceutical, designer, and experimental drugs.
History
Phencyclidine (PCP) is believed to be the first arylcyclohexylamine with recognized anesthetic properties, but several arylcyclohexylamines were described before PCP in the scientific literature, beginning with PCA (1-phenylcyclohexan-1-amine) the synthesis of which was first published in 1907. PCP itself was discovered in 1926 but not researched by the pharmaceutical industry until the 1950s. PCE was reported in 1953 and PCMo (4-(1-phenyl-cyclohexyl)-morpholine[1] see chart below for figure) in 1954, with PCMo described as a potent sedative.[2] Arylcyclohexylamine anesthetics were intensively investigated at Parke-Davis, beginning with the 1956 studies of PCP and later the related compound ketamine.[2] The 1970s saw the debut of these compounds, especially PCP and its analogues, as illicitly used recreational drugs due to their dissociative hallucinogenic and euphoriant effects. Since that time, the class has been expanded by scientific research into stimulant, analgesic, and neuroprotective agents, and also by clandestine chemists in search of novel recreational drugs.[3][4][5]
Structure
An arylcyclohexylamine is composed of a cyclohexylamine unit with an aryl moiety attachment. The aryl group is positioned geminal to the amine. In the simplest cases, the aryl moiety is typically a phenyl ring, sometimes with additional substitution. The amine is usually not primary; secondary amines such as methylamine or ethylamine, or tertiary cycloalkylamines such as piperidine and pyrrolidine, are the most commonly encountered N-substituents.
Pharmacology
Arylcyclohexylamines varyingly possess NMDA receptor antagonistic,[6][7] dopamine reuptake inhibitory,[8] and μ-opioid receptor agonistic[9] properties. Additionally, σ receptor agonistic,[10] nACh receptor antagonistic,[11] and D2 receptor agonistic[12] actions have been reported for some of these agents. Antagonism of the NMDA receptor confers anesthetic, anticonvulsant, neuroprotective, and dissociative effects; blockade of the dopamine transporter mediates stimulant and euphoriant effects as well as psychosis in high amounts; and activation of the μ-opioid receptor causes analgesic and euphoriant effects. Stimulation of the σ and D2 receptors may also contribute to hallucinogenic and psychotomimetic effects.[12]
These are versatile agents with a wide range of possible pharmacological activities depending on the extent and range to which chemical modifications are implemented.[13][14][15][16][17][18][19][20][21]Template:Excessive citations inline The various choice of substitutions that are made allows for "fine-tuning" of the pharmacological profile that results. As examples, BTCP is a selective dopamine reuptake inhibitor,[8] PCP is primarily an NMDA antagonist,[6] and BDPC is a potent μ-opioid agonist,[22] while PRE-084 is a selective sigma receptor agonist.[23] Thus, radically different pharmacology is possible through different structural combinations.
Notes on numbering
PCP itself is composed of three six-membered rings, which can each be substituted by a variety of groups. These are traditionally numbered in the older research as first the cyclohexyl ring, then the phenyl, and finally the piperidine ring, with the different rings represented by prime notation (') next to the number. For instance, 4-methyl-PCP, 4'-methyl-PCP and 4''-methyl-PCP are all known compounds, with similar activity but quite different potencies.
However, since the widespread sale of these compounds as grey-market designer drugs, nearly all such compounds that have come to prominence either have a bare cyclohexyl ring or a 2-ketocyclohexyl ring, while the piperidine is replaced by a variety of alkyl or cycloalkyl amines and most substitution has taken place on the phenyl ring. Consequently, it is common for widely used phenyl substituted analogues such as 3'-MeO-PCP and 3'-MeO-PCE to be referred to as 3-MeO-PCP and 3-MeO-PCE without the prime, even though this is technically incorrect and could lead to confusion.
List of arylcyclohexylamines
| Structures | Compound | Aryl Substituent | N Group | Cyclohexyl ring | CAS # |
|---|---|---|---|---|---|
| File:PCA structure.png | PCA[24] | Phenyl | NH2 | - | 1934-71-0 |
| File:PCM structure.png | PCM[24] | Phenyl | Methylamino | - | 2201-16-3 |
| File:Eticyclidine.svg | Eticyclidine | Phenyl | Ethylamino | - | 2201-15-2 |
| File:PCPr structure.svg | PCPr[25] | Phenyl | n-Propylamino | - | 18949-81-0 |
| File:PCiP structure.png | PCiP | Phenyl | Isopropylamino | - | 1195-42-2 |
| File:PCAL structure.png | PCAL [26] | Phenyl | Allylamino | - | 2185-95-7 |
| File:PCBu structure.png | PCBu | Phenyl | n-Butylamino | - | 73166-29-7 |
| File:PCEOH structure.png | PCEOH | Phenyl | Hydroxyethylamino | - | 2201-22-1 |
| File:PCMEA structure.png | PCMEA[27] | Phenyl | Methoxyethylamino | - | 2201-57-2 |
| File:PCEEA structure.png | PCEEA | Phenyl | Ethoxyethylamino | - | 1072895-05-6 |
| File:PCMPA structure.png | PCMPA | Phenyl | Methoxypropylamino | - | 2201-58-3 |
| File:PCDM structure.png | PCDM[24] | Phenyl | Dimethylamino | - | 2201-17-4 |
| File:Dieticyclidine.svg | Dieticyclidine | Phenyl | Diethylamino | - | 2201-19-6 |
| File:2-HO-PCP structure.png | 2-HO-PCP[6] | Phenyl | Piperidine | 2-Hydroxy | 94852-58-1 |
| File:2-Me-PCP structure.png | 2-Me-PCP[28] | Phenyl | Piperidine | 2-Methyl | 59397-29-4 |
| File:2-MeO-PCP structure.png | 2-MeO-PCP[29] | Phenyl | Piperidine | 2-Methoxy | 78636-34-7 |
| File:O-PCP structure.png | 2-Keto-PCP | Phenyl | Piperidine | 2-Keto | 101688-16-8 |
| File:O-PCE structure.png | Eticyclidone ("O-PCE") | Phenyl | Ethylamino | 2-Keto | 6740-82-5 |
| File:O-PCPr structure.png | 2-Keto-PCPr | Phenyl | n-Propylamino | 2-Keto | |
| File:4-Me-PCP structure.png | 4-Methyl-PCP | Phenyl | Piperidine | 4-Methyl | 19420-52-1 |
| File:4-Keto-PCP structure.png | 4-Keto-PCP[30] | Phenyl | Piperidine | 4-Keto | 65620-13-5 |
| File:2'-Cl-PCP structure.png | 2'-Cl-PCP | o-Chlorophenyl | Piperidine | - | 2201-31-2 |
| File:3'-Cl-PCP structure.png | 3'-Cl-PCP | m-Chlorophenyl | Piperidine | - | 2201-32-3 |
| File:2'-MeO-PCP structure.png | 2'-MeO-PCP | o-Methoxyphenyl | Piperidine | - | 2201-34-5 |
| File:3'-F-PCP structure.png | 3'-F-PCP[31] | m-Fluorophenyl | Piperidine | - | 89156-99-0 |
| File:3'-Me-PCP structure.png | 3'-Me-PCP[32] | m-Tolyl | Piperidine | - | 2201-30-1 |
| File:3'-Me-PCPy structure.png | 3'-Me-PCPy | m-Tolyl | Pyrrolidine | - | 1622348-63-3 |
| File:3'-NH2-PCP structure.png | 3'-NH2-PCP | m-Aminophenyl | Piperidine | - | 72242-00-3 |
| File:3-HO-PCP.png | 3'-HO-PCP | m-Hydroxyphenyl | Piperidine | - | 79787-43-2 |
| File:3-MeO-PCP structure.svg | 3'-MeO-PCP | m-Methoxyphenyl | Piperidine | - | 72242-03-6 |
| File:MDPCP structure.png | 3',4'-MD-PCP | 3,4-Methylenedioxyphenyl | Piperidine | - | |
| File:3-Me-PCE.png | 3'-Me-PCE | m-Tolyl | Ethylamino | - | 2201-64-1 |
| File:3-MeO-PCE.svg | 3'-MeO-PCE | m-Methoxyphenyl | Ethylamino | - | 1364933-80-1 |
| File:3'-OH-PCE structure.png | 3'-HO-PCE | m-Hydroxyphenyl | Ethylamino | - | |
| File:3'-MeO-PCPr structure.png | 3'-MeO-PCPr | m-Methoxyphenyl | n-Propylamino | - | 1364933-81-2 |
| File:3'-OH-PCPr structure.png | 3'-HO-PCPr | m-Hydroxyphenyl | n-Propylamino | - | |
| File:MDPCPr structure.png | 3',4'-MD-PCPr | 3,4-Methylenedioxyphenyl | n-Propylamino | - | |
| File:3'-MeO-PCPy structure.png | 3'-MeO-PCPy[32] | m-Methoxyphenyl | Pyrrolidine | - | 1364933-79-8 |
| File:4'-HO-PCP structure.png | 4'-HO-PCP | p-Hydroxyphenyl | Piperidine | - | 66568-88-5 |
| File:4-methoxyphencyclidine.png | Methoxydine (4'-MeO-PCP) | p-Methoxyphenyl | Piperidine | - | 2201-35-6 |
| File:4'-MeO-PCE structure.png | 4'-MeO-PCE | p-Methoxyphenyl | Ethylamino | - | |
| File:4'-F-PCP structure.png | 4'-F-PCP[31] | p-Fluorophenyl | Piperidine | - | 22904-99-0 |
| File:4'-F-PCPy structure.png | 4'-F-PCPy | p-Fluorophenyl | Pyrrolidine | - | |
| File:Arketamine structure.svg | Arketamine | o-Chlorophenyl | Methylamino | 2-Keto | 33643-49-1 |
| File:Deschloroketamine.png | Deschloroketamine | Phenyl | Methylamino | 2-Keto | 7063-30-1 |
| File:Esketamine2DCSD.svg | Esketamine | o-Chlorophenyl | Methylamino | 2-Keto | 33643-46-8 |
| File:Ketamine2DCSD.svg | Ketamine | o-Chlorophenyl | Methylamino | 2-Keto | 6740-88-1 |
| File:(2R,6R)-Hydroxynorketamine Formula V1.svg | Hydroxynorketamine | o-Chlorophenyl | NH2 | 2-Keto, 6-Hydroxy | 81395-70-2 |
| File:N-Ethylnorketamine structure.png | Ethketamine | o-Chlorophenyl | Ethylamino | 2-Keto | 1354634-10-8 |
| File:NPNK structure.png | NPNK | o-Chlorophenyl | n-Propylamino | 2-Keto | 2749326-65-4 |
| File:Methoxyketamine.svg | Methoxyketamine | o-Methoxyphenyl | Methylamino | 2-Keto | 7063-51-6 |
| File:2-MeO-NEK structure.png | 2-MeO-NEK[33] | o-Methoxyphenyl | Ethylamino | 2-Keto | |
| File:OMDCK structure.png | oMDCK[34] | o-Tolyl | Methylamino | 2-Keto | 7063-37-8 |
| File:MMDCK structure.png | mMDCK | m-Tolyl | Methylamino | 2-Keto | |
| File:Meta-ketamine structure.png | meta-Ketamine | m-Chlorophenyl | Methylamino | 2-Keto | 7063-53-8 |
| File:Isoketamine structure.png | iso-Ketamine | o-Chlorophenyl | Methylamino | 4-Keto | |
| File:2-Fluorodeschloroketamine.svg | 2-Fluorodeschloroketamine | o-Fluorophenyl | Methylamino | 2-Keto | 111982-50-4 |
| File:3FDCK structure.png | 3-Fluorodeschloroketamine | m-Fluorophenyl | Methylamino | 2-Keto | 2657761-23-2 |
| File:Blixeprodil.svg | Blixeprodil | p-Fluorophenyl | Methylamino | 2-Keto | 2881017-49-6 |
| File:Bromoketamine structure.png | Bromoketamine | o-Bromophenyl | Methylamino | 2-Keto | 120807-70-7 |
| File:TFMDCK structure.png | TFMDCK | o-Trifluoromethylphenyl | Methylamino | 2-Keto | 1782149-73-8 |
| File:SN35210 structure.png | SN 35210[35] | o-Chlorophenyl | Carbomethoxybutylamino | 2-Keto | 1450615-41-4 |
| File:Methoxetamine2DCSD.svg | Methoxetamine | m-Methoxyphenyl | Ethylamino | 2-Keto | 1239943-76-0 |
| File:Methoxmetamine.png | Methoxmetamine | m-Methoxyphenyl | Methylamino | 2-Keto | 1781829-56-8 |
| File:Methoxpropamine.svg | Methoxpropamine | m-Methoxyphenyl | n-Propylamino | 2-Keto | 2504100-71-2 |
| File:MXiPr structure.png | MXiPr | m-Methoxyphenyl | i-Propylamino | 2-Keto | |
| File:Ethoxetamine structure.png | Ethoxetamine | m-Ethoxyphenyl | Ethylamino | 2-Keto | |
| File:DMXE structure.svg | Deoxymethoxetamine (3-Me-2'-Oxo-PCE) | m-Tolyl | Ethylamino | 2-Keto | 2666932-45-0 |
| File:Br-MXE structure.png | Br-MXE | 2-bromo-5-methoxyphenyl | Ethylamino | 2-Keto | |
| File:HXE structure.png | Hydroxetamine (HXE) | m-Hydroxyphenyl | Ethylamino | 2-Keto | 1620054-73-0 |
| File:HXM structure.png | HXM | m-Hydroxyphenyl | Methylamino | 2-Keto | |
| File:2F-NENDCK structure.png | 2F-NENDCK | o-Fluorophenyl | Ethylamino | 2-Keto | |
| File:FXE structure.png | Fluorexetamine (FXE) | m-Fluorophenyl | Ethylamino | 2-Keto | |
| File:Phencyclidine structure.svg | Phencyclidine (PCP) | Phenyl | Piperidine | - | 77-10-1 |
| File:PC3MP structure.png | PC3MP | Phenyl | 3-Methylpiperidine | - | 2201-41-4 |
| File:PC4MP structure.png | PC4MP | Phenyl | 4-Methylpiperidine | - | 2201-42-5 |
| File:Rolicyclidine.svg | Rolicyclidine (PCPy) | Phenyl | Pyrrolidine | - | 2201-39-0 |
| File:PCDMPy structure.png | PCDMPy | Phenyl | 3,3-Dimethylpyrrolidine | - | |
| File:PCMo structure.png | PCMo | Phenyl | Morpholine | - | 2201-40-3 |
| File:2'-MeO-PCMo structure.png | Methoxy-PCM[7] (2'-MeO-PCMo) | o-Methoxyphenyl | Morpholine | - | 1314323-88-0 |
| File:3-MeO-PCMo.svg | 3'-MeO-PCMo | m-Methoxyphenyl | Morpholine | - | 138873-80-0 |
| File:4'-MeO-PCMo structure.png | 4'-MeO-PCMo | p-Methoxyphenyl | Morpholine | - | |
| File:4'-Me-PCMo structure.png | Methyl-PCM[36] (4'-Me-PCMo) | p-Tolyl | Morpholine | - | 120803-52-3 |
| File:2'-Me-4'-HO-PCMo structure.png | Hydroxy-methyl-PCM | 2-Methyl-4-hydroxyphenyl | Morpholine | - | 1314323-89-1 |
| File:PYCP structure.png | PYCP [37] | 2-Pyridinyl | Piperidine | - | |
| File:TCM structure.png | TCM | 2-Thienyl | Methylamino | - | 139401-07-3 |
| File:TCE structure.png | TCE | 2-Thienyl | Ethylamino | - | 101589-62-2 |
| File:TCPr structure.png | TCPr [38] | 2-Thienyl | Propylamino | - | |
| File:Tenocyclidine.svg | Tenocyclidine (TCP) | 2-Thienyl | Piperidine | - | 21500-98-1 |
| File:T3CP structure.png | T3CP | 3-Thienyl | Piperidine | - | 19420-50-9 |
| File:TCPy structure.png | TCPy | 2-Thienyl | Pyrrolidine | - | 22912-13-6 |
| File:Tilmetamine structure.png | Tilmetamine | 2-Thienyl | Methylamino | 2-Keto | |
| File:Tiletamine.svg | Tiletamine | 2-Thienyl | Ethylamino | 2-Keto | 14176-49-9 |
| File:MXTE structure.png | MXTE | 4-Methoxy-2-thienyl | Ethylamino | 2-Keto | |
| File:Gacyclidine.png | Gacyclidine | 2-Thienyl | Piperidine | 2-Methyl | 68134-81-6 |
| File:Bromadol Skeletal.png | BDPC | p-Bromophenyl | Dimethylamino | 4-Phenethyl-4-hydroxy | 77239-98-6 |
| File:C-8813.svg | C-8813 | p-Bromophenyl | Dimethylamino | 4-(thiophen-2-yl)ethyl-4-hydroxy | 616898-54-5 |
| File:Dimetamine structure.png | Dimetamine[39] | p-Tolyl | Dimethylamino | 4-Keto | 65619-06-9 |
| File:Ahmadi pcp 2010.svg | 3''-OH-2'-Me-PCP [40] | o-Tolyl | 3-Hydroxypiperidine | - | |
| File:1-(1-PhCHX)-4-Ph-4-OH-piperidine structure.png | 4''-Ph-4''-OH-PCP [41] | Phenyl | 4-Phenyl-4-hydroxypiperidine | - | 77179-39-6 |
| File:BTCP.svg | BTCP[42] | Benzothiophen-2-yl | Piperidine | - | 112726-66-6 |
| File:BTCPy structure.png | BTCPy[10] | Benzothiophen-2-yl | Pyrrolidine | - | |
| File:GK-189 structure.png | GK-189[43] | Naphthalen-2-yl | Piperidine | - | 81490-58-6 |
Related compounds
Other similar compounds exist where the base ring has been varied, or the amine chain replaced with other groups.[44] More cycloalkane ring sizes have been experimented with than just purely thinking in terms of the cyclohexylamine. The cyclopentyl homologue of PCP is active with around one-tenth the potency,[45] while the cycloheptyl and cyclooctyl derivatives are inactive, though some substituted arylcycloheptylamines retain activity.[46] The requisite cycloalkylketone is reacted with PhMgBr; 3° alcohol is then reacted with NaN3; azide then reduced with LAH. Then in the final step the piperidine ring is constructed with 1-5-dibromo-pentane.[47] Other compounds are known where the cyclohexyl base ring is replaced by rings such as norbornyl, adamantyl,[48] tetralin, oxane, thiane [49] or piperidine.[50] Conformationally constrained analogs have been prepared and researched by Morieti et al.[51]
| Structure | Compound | Aryl Substituent | N Group | Base ring | CAS # |
|---|---|---|---|---|---|
| File:Ketamir structure.png | Ketamir | 2-Chlorophenyl | Methylamine | 2-Oxocyclopentyl | |
| File:PCPEP structure.png | PCPEP | Phenyl | Piperidine | Cyclopentyl | 23036-19-3 |
| File:3F-PCHEPy structure.png | 3F-PCHEPy | 3-Fluorophenyl | Pyrrolidine | Cycloheptyl | |
| File:3-MeO-PBCHP structure.png | 3-MeO-PBCHP | 3-Methoxyphenyl | Piperidine | Bicyclo[2.2.1]heptane | |
| File:PADP structure.png | PADP (P2AP) | Phenyl | Piperidine | Adamantyl | 72241-99-7 |
| File:Ahmadi 2010.svg | 3-MeO-PTP | 3-Methoxyphenyl | Piperidine | Tetralin | |
| File:HHFA structure.png | HHFA | Fused phenyl | Amino | Hexahydrofluorene | |
| File:DHPQ structure.png | DHPQ | Phenyl | Decahydroquinoline | ||
| File:POXP structure.png | POXP | Phenyl | Piperidine | Oxane | |
| File:PTHP structure.png | PTHP | Phenyl | Piperidine | Thiane | |
| File:MPBPip structure.png | MPBPip | Phenyl | Piperidine | N-Methylpiperidine | 36882-04-9 |
| File:BnCP structure.png | BnCP | Benzyl | Piperidine | Cyclohexyl | 22912-07-8 |
| File:YNCP structure.png | YNCP | Ethynyl | Piperidine | Cyclohexyl | 51165-02-7 |
| File:ALCP structure.png | ALCP | Allyl | Piperidine | Cyclohexyl | 7418-80-6 |
| File:F-17475 structure.png | F-17475 | Phenyl | Diethylamide | 3-Aminocyclobutyl | 1612885-86-5 |
| File:Piritramide2DACS.svg | Piritramide | Replaced by carboxamide | Piperidine | N-(3-cyano-3,3-diphenylpropyl)piperidine | 302-41-0 |
| File:PRE-084 SVG file.svg | PRE-084 | Phenyl | Morpholinylethylcarboxylate | Cyclohexyl | 138847-85-5 |
| File:Clofenciclan Structural Formulae.png | Clofenciclan | p-Chlorophenyl | Diethylaminoethoxy | Cyclohexyl | 5632-52-0 |
References
<templatestyles src="Reflist/styles.css" />
- ↑ Script error: No such module "citation/CS1".
- ↑ a b Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ a b c Script error: No such module "Citation/CS1".
- ↑ a b Script error: No such module "Citation/CS1".
- ↑ a b Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ a b Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ a b Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ a b c Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ a b Script error: No such module "Citation/CS1".
- ↑ a b Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ <templatestyles src="Citation/styles.css"/>Template:Citation/make link, Kruegel AC, Sames D, Hashimoto K, "Arylcyclohexylamine derivatives and their use in the treatment of psychiatric disorders", published Script error: No such module "auto date formatter"., assigned to Gilgamesh Pharmaceuticals, Inc. and The Trustees Of Columbia University In The City Of New York.Script error: No such module "Check for unknown parameters".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Kamenka JM, et al. Substituted cyclic amines and pharmaceutical composition containing them. Patent US5248686, 28 September 1993
- ↑ Wallach JV. Structure activity relationship (SAR) studies of arylcycloalkylamines as N-methyl-D-aspartate receptor antagonists. PhD. Thesis, University of the Sciences in Philadelphia, 19 Dec 2014.
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Sisco E, Urbas A. Identification and Characterization of Designer Phencyclidines (PCPs) in Forensic Casework
- ↑ Gerhard O, Eberhard E. 4-amino-piperidines. US3311624A
- ↑ Script error: No such module "Citation/CS1".
Script error: No such module "Check for unknown parameters".
Further reading
<templatestyles src="Refbegin/styles.css" />
- Script error: No such module "Citation/CS1".
External links
- Synthesis and Effects of PCP Analogs
- Interview with a Ketamine Chemist
- New Drugs: Designing Novel Arylcyclohexylamines
Script error: No such module "Navbox with collapsible groups". Script error: No such module "Navbox". Script error: No such module "Navbox". Script error: No such module "Navbox". Template:Ionotropic glutamate receptor modulators Template:Monoamine reuptake inhibitors Template:Chemical classes of psychoactive drugs